Techne company information, Employees & Contact Information

Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research PR Newswire

Bio-Techne (NASDAQ: TECH) launches ProximityScope on BOND RX for protein interactions Stock Titan

Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results Investing News Network

Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results Eastern Progress

Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results Yahoo Finance

Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 Sahm

Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology Business Wire

Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls Nasdaq

Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report PR Newswire

Bio-Techne Announces Exosome Diagnostics Divestiture Yahoo Finance

TECHNE BAM | Brooklyn Academy of Music

Bio-Techne to Present at Upcoming Investor Conferences Investing News Network

Revolutionary RNA-Protein Detection: Bio-Techne's New Tech Could Transform Cancer Diagnostics Stock Titan

Bio-Techne to Present at Upcoming Investor Conferences PR Newswire

Bio-Techne's Simple Western Enables Breakthrough FDA Approval for Rare Skin Disease Gene Therapy Stock Titan

ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc. PR Newswire

Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 PR Newswire

BIO-TECHNE DECLARES DIVIDEND PR Newswire

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany PR Newswire

Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors PR Newswire

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development PR Newswire

Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System PR Newswire

Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications PR Newswire

BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM PR Newswire

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine PR Newswire

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES PR Newswire

BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO PR Newswire

Bio-Techne Drug Target Review

BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER PR Newswire

Bio-Techne Announces Opening Of New Canadian Facility PR Newswire

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC PR Newswire

Bio-Techne Launches The Mauriceflex™ System, Adding cIEF Fractionation Capability To The Gold Standard Maurice Assays Bioprocess Online

Bio-Techne to Acquire Asuragen PR Newswire

B-MoGen Biotechnologies, a Bio-Techne Company, Announces Opening of 2 Class 7 Clean Suites for Cellular Therapy Manufacturing BioInformant

Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc. PR Newswire

Lunaphore to Get Acquired by Bio-Techne Business Wire

Bio-Techne Launches ExCellerate™ iPSC Expansion Medium BioInformant

Bio-Techne Adds Two New Directors to Its Board PR Newswire

Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland PR Newswire

Bio-Techne To Acquire Quad Technologies PR Newswire

Bio-Techne Introduces RePlex Capabilities For Simple Western Assays On Jess™ PR Newswire

Bio-Techne Acquires Trevigen Inc. PR Newswire

Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics PR Newswire

BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY Stock Titan

FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx™ Prostate IntelliScore™ (EPI) Test PR Newswire

Bio-Techne Announces Agreement To Acquire Advanced Cell Diagnostics PR Newswire

Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult "Ground-state" Stem Cell Technology PR Newswire

VSIG‐3 as a ligand of VISTA inhibits human T‐cell function - Wang - 2019 - Immunology Wiley Online Library

Bio-Techne Realigns for Growth Genetic Engineering and Biotechnology News

Get Thermal Cyclers at a record-breaking low price with Latest Offer Labmate Online